Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

The DMB promoter: delineation, in vivo footprint, trans-activation, and trans-dominant suppression.

Ting JP, Wright KL, Chin KC, Brickey WJ, Li G.

J Immunol. 1997 Dec 1;159(11):5457-62.

PMID:
9548486
2.

The two novel MHC class II transactivators RFX5 and CIITA both control expression of HLA-DM genes.

Kern I, Steimle V, Siegrist CA, Mach B.

Int Immunol. 1995 Aug;7(8):1295-9.

PMID:
7495736
3.
4.

HLA-DMA and HLA-DMB gene expression functions through the conserved S-X-Y region.

Westerheide SD, Louis-Plence P, Ping D, He XF, Boss JM.

J Immunol. 1997 May 15;158(10):4812-21.

PMID:
9144496
5.

CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex.

Masternak K, Muhlethaler-Mottet A, Villard J, Zufferey M, Steimle V, Reith W.

Genes Dev. 2000 May 1;14(9):1156-66.

6.

The transcription factor RFX protects MHC class II genes against epigenetic silencing by DNA methylation.

Seguín-Estévez Q, De Palma R, Krawczyk M, Leimgruber E, Villard J, Picard C, Tagliamacco A, Abbate G, Gorski J, Nocera A, Reith W.

J Immunol. 2009 Aug 15;183(4):2545-53. doi: 10.4049/jimmunol.0900376. Epub 2009 Jul 20.

7.

CIITA-dependent and -independent class II MHC expression revealed by a dominant negative mutant.

Zhou H, Su HS, Zhang X, Douhan J 3rd, Glimcher LH.

J Immunol. 1997 May 15;158(10):4741-9.

PMID:
9144488
10.

X box-like sequences in the MHC class II region maintain regulatory function.

Gomez JA, Majumder P, Nagarajan UM, Boss JM.

J Immunol. 2005 Jul 15;175(2):1030-40.

11.

Regulation of major histocompatibility (MHC) class II human leukocyte antigen-DR alpha gene expression in thyrocytes by single strand binding protein-1, a transcription factor that also regulates thyrotropin receptor and MHC class I gene expression.

Balducci-Silano PL, Suzuki K, Ohta M, Saito J, Ohmori M, Montani V, Napolitano G, Shong M, Taniguchi SI, Pietrarelli M, Lavaroni S, Mori A, Singer DS, Kohn LD.

Endocrinology. 1998 May;139(5):2300-13.

PMID:
9564838
12.

Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.

Souwer Y, Chamuleau ME, van de Loosdrecht AA, Tolosa E, Jorritsma T, Muris JJ, Dinnissen-van Poppel MJ, Snel SN, van de Corput L, Ossenkoppele GJ, Meijer CJ, Neefjes JJ, Marieke van Ham S.

Br J Haematol. 2009 May;145(3):334-43. doi: 10.1111/j.1365-2141.2009.07625.x. Epub 2009 Feb 24.

PMID:
19245431
14.

Different levels of control prevent interferon-gamma-inducible HLA-class II expression in human neuroblastoma cells.

Croce M, De Ambrosis A, Corrias MV, Pistoia V, Occhino M, Meazza R, Giron-Michel J, Azzarone B, Accolla RS, Ferrini S.

Oncogene. 2003 Oct 30;22(49):7848-57.

PMID:
14586411
15.

Class II transactivator promoter activity is suppressed through regulation by a trophoblast noncoding RNA.

Geirsson A, Paliwal I, Lynch RJ, Bothwell AL, Hammond GL.

Transplantation. 2003 Jul 27;76(2):387-94.

PMID:
12883198
16.

A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients.

Masternak K, Barras E, Zufferey M, Conrad B, Corthals G, Aebersold R, Sanchez JC, Hochstrasser DF, Mach B, Reith W.

Nat Genet. 1998 Nov;20(3):273-7.

PMID:
9806546
17.

Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation.

Li D, Qian L, Chen C, Shi M, Yu M, Hu M, Song L, Shen B, Guo N.

J Immunol. 2009 Feb 15;182(4):1799-809. doi: 10.4049/jimmunol.0802686.

18.

Long distance control of MHC class II expression by multiple distal enhancers regulated by regulatory factor X complex and CIITA.

Krawczyk M, Peyraud N, Rybtsova N, Masternak K, Bucher P, Barras E, Reith W.

J Immunol. 2004 Nov 15;173(10):6200-10.

19.

HLA class II expression in uninducible hepatocarcinoma cells after transfection of AIR-1 gene product CIITA: acquisition of antigen processing and presentation capacity.

Sartoris S, Valle MT, Barbaro AL, Tosi G, Cestari T, D'Agostino A, Megiovanni AM, Manca F, Accolla RS.

J Immunol. 1998 Jul 15;161(2):814-20.

20.

Major histocompatibility class II HLA-DR alpha gene expression in thyrocytes: counter regulation by the class II transactivator and the thyroid Y box protein.

Montani V, Taniguchi SI, Shong M, Suzuki K, Ohmori M, Giuliani C, Napolitano G, Saji M, Fiorentino B, Reimold AM, Ting JP, Kohn LD, Singer DS.

Endocrinology. 1998 Jan;139(1):280-9.

PMID:
9421426

Supplemental Content

Support Center